## Abstract ## Introduction The relative rarity of mucosal melanomas of the head and neck (MMHN) has made analysis of treatment approaches difficult. Advances in diagnostic techniques and treatment interventions have had obvious impact on outcomes in cutaneous melanoma, but the effects on outcome
FDG PET for Mucosal Malignant Melanoma of the Head and Neck
β Scribed by Gerhard W. Goerres; Sandro J. Stoeckli; Gustav K. von Schulthess; Hans C. Steinert
- Book ID
- 110083943
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 455 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Forty-two patients with mucosal melanoma of the head and neck were treated at the M. D. Anderson Cancer Center from 1944-1989. Their records were evaluated regarding: location of the primary, stage of the disease at presentation, type of treatment, location of recurrences, and overall survival. Thes
## Abstract Mucosal melanoma of the head and neck is a rare condition. This study presents a review of 26 patients with such tumors, followed up at a minimum of 5 years. The 5βyear survival rate in this group was 38%. Recurrences with a fatal outcome, however, have been encountered up to 12 years a
## Abstract Sixtyβnine patients with head and neck melanoma were prospectively evaluated from 1971 to 1977. Patients presenting for initial therapy underwent wide excision of their primary tumor, and those with deeply invasive melanoma also underwent regional lymphadenectomy, whether their nodes we
## Abstract 18βFDGβPET has utility for the identification of the unknown primary head and neck squamous carcinoma, distant metastases or second primary carcinomas, and recurrent HNSCC in the postβtreatment setting. PET has a high negative predictive value in the detection of recurrent HNSCC. Standa